Tag: NYMX

Blue Horseshoe Stocks: Fresh Options Ideas & More

Pazoo Inc. PZOO

PZOO has been progressing well in the past several sessions since we last touched base with the stock a couple of weeks ago. We had just received word from the company that its wholly-owned CannabisKing Distribution subsidiary had struck two significant deals (Links to PR’s below), and witnessed a two-session swing of 74% as a result.

After regrouping and bouncing off of a low of .0046 (07/13), PZOO has made continuously higher lows for the rest of this month, and pushed its PPS back to the current range (.006-.007). We’ve provided the following snapshot illustrating the current bullish characteristics of the chart.

We’ll be on the lookout for further updates regarding the many irons PZOO currently has in the fire, and you can be sure that we’ll pass them along as the stories develop.

Fresh Options Ideas

As we approach midweek with earnings drops in full swing, we’re going to formulate a few corresponding options ideas we feel have the potential to perform well:

Ford Motor Co. (F) – Ford set record North American profits and beat Wall St. expectations handily this morning. The stock is gapping up moderately, so we’re going to taking a look at F Weekly $14.50 and $15 Calls, which should produce some nice action.

Pfizer, Inc. PFE –  Pfizer also had an earnings beat on their Q2 release today, and our related options ideas will be to monitor PFE Weekly $34.50 and $35 Calls.

Baidu, Inc. BIDU – After an extreme analyst downgrade, BIDU is taking an absolute beating, and is leading us to include a rare idea on the bearish side of things; we’ll be tracking BIDU Weekly Puts in the $180-175 Range.

Cytori Therapeutics, Inc. CYTX

We also want to raise a flag on a familiar stock cropping up in the news feed this morning. Early this year we saw CYTX make a huge move, and after spending the last several months in a general downtrend, some FDA-related news out this morning could be just the thing to catalyze a reversal. We’ll be watching intently for that possibility; check out the news below.

Cytori Therapeutics, Inc. (CYTX) today announced that Kerastem Technologies, a wholly owned subsidiary of Bimini Technologies, received U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to conduct a clinical trial studying the safety and feasibility of its technology for the treatment of female and early male pattern baldness (androgenic alopecia). >> FULL PR

Extended Watchlist:
PGNX, SDRL, NYMX, AKS, RJET

Blue Horseshoe Stocks: NYMX Update, LTNC & More

Nymox Pharmaceutical Corp. NYMX

We certainly hope our readers read over yesterday’s morning report thoroughly, because it would mean that people caught our closing note on NYMX in the extended watchlist. We mentioned the big gap-down on the stock, and that we’d be on the lookout for a reversal.

It didn’t take any time at all for NYMX to behave according to our suspicions; it opened at a low of .59 and immediately began its recovery, which lasted for a good portion of the day and culminated in a high of 1.03. Big congratulations are in order for anyone that took advantage of that 74% intraday rip.

The huge gap-down was apparently caused from a knee-jerk reaction to Sunday’s announcement that the company’s prostate cancer treatment (NX-1207) failed to meet primary efficacy endpoints in Phase 3 studies.

It’s fair to mention that prior to yesterday’s session, NYMX was trading at a base level just below $5 (50DMA of 4.77) and yesterday’s bottom-bounce carried it back up to a mere fraction of that level, so it will be interesting to see how much of its lost ground could potentially be recovered in coming sessions.

Labor Smart Inc. LTNC

We caught LTNC on a routine news scan this morning, and we really like what we learned from a quick glance at the PR. LTNC announced that its October revenues set a company record ($2.7M), contributed to a 23-month streak of year-over-year increases, and brought total revenue for 2014 over the $20M-mark.

Those highlights are substantial enough to have us put LTNC on our radar moving forward. A company exhibiting growth patterns like these is certainly worth watching.

The chart is also coming off of a relative bottom, so it could be that we’ve stumbled across LTNC at just the right time.

Extended Watchlist:
CDTI, CDVI, ODP, VSR, MWW, FCEL

Blue Horseshoe Stocks: FCGD, PZOO Updates

First Columbia Gold Corp. FCGD

FCGD continued to push its limits on Friday; if you recall, the low we observed following our in our initial report last Monday was .075. We witnessed a subsequent run to .098, which was followed by a pullback to support at  .076. From that level on Friday, FCGD went to to set a new high in to the close (.105), an intraday gain of 38% on nearly twice the monthly average volume.

LINKS:

Our Exclusive Interview with FCGD’s New CEO Jason Castenir on Thursday provided over 20 minutes of exclusive content on FCGD, so go check it out.

View a copy of Monday’s Initial FCGD Report Here

MORE INFO @ FirstColombiaGold.com
or connect with FCGD on Facebook, Twitter and YouTube

Pazoo, Inc. PZOO

We’ve kept an active eye on PZOO since we introduced it to our reports two Mondays ago at a low of .0225. The stock has since established a higher level of support above the 50DMA, which was something we were looking to have happen.

We also saw PZOO achieve a new high last week, hitting .038 (A 69% increase from our observed low) a mark that will act as key resistance moving forward.

The company set a new traffic milestone for their online health and wellness portal as well, updating us of the achievement on Thursday:

WHIPPANY, NJ / ACCESSWIRE / October 30, 2014 / Pazoo, Inc. (PZOO) (German WKN#: A1J3DK) is pleased to report that traffic surged passed the previous high of 203,000 visitors in one day (previously recorded May of 2014) to 239,786 on October 27, 2014, as reported by Google Analytics. >> VIEW PR

Groupon, Inc. GRPN

We also need to pat ourselves on the back for taking a timely look at GRPN on Friday and mentioning it in our extended watchlist. The stock surged from a low of 6.45 and ended up peaking at 7.42, gaining 16.5% intraday on almost six times the one-month average volume.

That’s quite a respectable single-session spike from a stock in this price range.

Extended Watchlist:
GERN, OIBR, ARNA, MNDO, NYMX(Gap-down, Watching for Possible Reversal)